Hepion Pharmaceuticals Inc
NASDAQ:HEPA
Hepion Pharmaceuticals Inc Stock, NASDAQ:HEPA
399 Thornall Street, 1st floor, Edison, New Jersey 08837
United States of America
Phone: +1.732.902.4000
Number of Employees: 13
Description
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate CRV431, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Edison, NJ.